Platelets upregulate tumor cell programmed death ligand 1 in an epidermal growth factor receptor-dependent manner in vitro

Programmed death ligand 1 (PD-L1) is an immune checkpoint protein that suppresses cytotoxic T lymphocytes and is often overexpressed in cancers. Due to favorable clinical trial results, immune checkpoint inhibition (ICI) is part of Food and Drug Administration approved immuno-oncology therapies; how...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Qiuchen, Malloy, Michael W., Roweth, Harvey G., McAllister, Sandra S., Italiano, Joseph E., Battinelli, Elisabeth M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2022
Materias:
Stimulus Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582587/
https://www.ncbi.nlm.nih.gov/pubmed/35482455
http://dx.doi.org/10.1182/bloodadvances.2021006120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582587/
https://www.ncbi.nlm.nih.gov/pubmed/35482455
http://dx.doi.org/10.1182/bloodadvances.2021006120

Ejemplares similares